{"database": "lobbying", "table": "lobbying_activities", "rows": [[3185159, "438d4de9-ed81-4804-8a09-6f8a4ff0cb99", "Q2", "E3 STRATEGIC CONSULTING GROUP", 401104104, "PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION", 2024, "second_quarter", "PHA", "Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, and employment issues, generally; S.127 - Pharmacy Benefit Manager Transparency Act of 2023; S.113 - Prescription Pricing for the People Act of 2023; H.R.830 - HELP Copays Act; S. 1542 - Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act\"); HR 4895 - H.R. 4895: Lowering Drug Costs for American Families Act; H.R. 2880: Protecting Patients Against PBM Abuses Act; HR 6283 - The Drug Act; HR 5378 - Lower Costs, More Transparency Act.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2024-07-01T16:18:13-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3185159"], "units": {}, "query_ms": 18.274632981047034, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}